TIM
TECH icon

Tevis Investment Management’s Bio-Techne TECH Stock Holding History

Tevis Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,784
Closed -$490K – 514
2021
Q4 		$490K Buy
+3,784
New +$464K 0.43% 73

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Tevis Investment Management's TECH Position: Q1 2022 in Review

Tevis Investment Management sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 3,784 shares — an estimated $490K sold.

Tevis Investment Management first reported a position in TECH in Q4 2021 and held it in 1 quarter. The position peaked at $490K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • Tevis Investment Management reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
  • Tevis Investment Management sold 3,784 Bio-Techne shares in Q1 2022, an estimated $490K.
  • Tevis Investment Management first reported a position in Bio-Techne in Q4 2021 and held it in 1 quarter.
  • Tevis Investment Management's Bio-Techne position peaked at $490K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Tevis Investment Management's 13F filing for Q1 2022, filed 5 Aug 2022.